New Key Statistics Module, Z-Score and F-Score
SZSE:301130 Key Ratios
Market Cap ¥ M | 2,228.57 |
Enterprise Value ¥ M | 1,825.10 |
P/E(ttm) | 50.15 |
PE Ratio without NRI | 51.17 |
Forward PE Ratio | -- |
Price/Book | 2.48 |
Price/Sales | 8.86 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.48 |
Revenue (TTM) ¥ M | 247.00 |
EPS (TTM) ¥ | 0.55 |
Beneish M-Score | -2.53 |
10-y EBITDA Growth Rate % | 4.20 |
5-y EBITDA Growth Rate % | -6.90 |
y-y EBITDA Growth Rate % | 42.00 |
EV-to-EBIT | 29.76 |
EV-to-EBITDA | 29.76 |
PEG | -- |
Shares Outstanding M | 80.80 |
Net Margin (%) | 17.48 |
Operating Margin % | 14.87 |
Pre-tax Margin (%) | 19.98 |
Quick Ratio | 8.43 |
Current Ratio | 8.89 |
ROA % (ttm) | 4.29 |
ROE % (ttm) | 4.62 |
ROIC % (ttm) | 6.35 |
Dividend Yield % | 0.96 |
Altman Z-Score | 17.97 |
SZSE:301130 Number of Guru Trades
SZSE:301130 Volume of Guru Trades
Gurus Latest Trades with SZSE:301130
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301130 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd Insider Transactions
No Available Data